ArticleThe Journal of clinical investigation2019

MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.